$GL · GLOBE LIFE INC.
Globe Life reported Q3 2026 net income of $4.62 per diluted share, down from $4.73 a year ago, while net operating income rose slightly to $4.84 from $4.81. Total premium revenue grew 7% to $1.31B. The company cut full-year 2026 net operating income guidance to $15.35–$15.65, citing high-severity claims at Evry and a CMS claims processing delay that drove a $6.4M underwriting loss at United American. FY2027 guidance was initiated at $16.10–$17.10 per share.
- Net income fell to $4.62 per diluted share from $4.73 YoY, while net operating income edged up to $4.84 from $4.81.
- Full-year 2026 net operating income guidance cut to $15.35–$15.65, down from prior implied ~$15.80+ midpoint.
- United American posted a health underwriting loss of $6.4M, driven by ~$16M Evry loss and ~$7M in excess Medicare Supplement claims.
- Life underwriting margin declined 5% YoY to $458M; Liberty National margin fell 27% on assumption update fluctuations.
- Share repurchases raised to $725M–$775M for FY2026 from prior $670M–$700M; 1.1M shares bought at $175.61 avg.
Extended-hours trading shows GL at $162.28, down 4.33% from the regular-session close of $169.72. The guidance cut and United American segment loss are driving the selloff despite the raised buyback authorization.
A rare guidance cut from Globe Life, driven by segment-specific losses rather than macro conditions, raises questions about the United American division's trajectory heading into 2027.
Life insurers are benefiting from higher interest rates (GL's fixed maturity yield rose to 5.33% from 5.26% YoY), but health segment volatility at United American and Medicare Supplement exposure create idiosyncratic headwinds versus peers.
United American's Evry group health business is still scaling and producing underwriting losses (~$16M this quarter). CMS claims processing delays caused ~$7M in excess Medicare Supplement claims, a risk that could recur.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.